Wiltrud Treffenfeldt is on the board of ProBioGen AG, BRAIN Biotech AG and Dow Olefinverbund GmbH. Dr. Treffenfeldt previously occupied the position of Director-Bioprocess Development at The Dow Chemical Co. and Principal at Degussa AG.
Dr. Treffenfeldt received a doctorate from the University of Dortmund and an undergraduate degree from Technical University of Berlin.
|